References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (ed. 3). Washington, DC 1980
- Burton J. L., Laschet U., Shuster S. Reduction of sebum excretion in man by the antiandrogen, cyproterone acetate. British Journal of Dermatology 1973a; 89: 487–490
- Burton J. L., Cartlidge M., Cartlidge N. E. F., Schuster S. Sebum secretion in parkinsonism. British Journal of Dermatology 1973b; 88: 263–266
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (ed. 3). Washington, DC 1980
- Burton J. L., Laschet U., Shuster S. Reduction of sebum excretion in man by the antiandrogen, cyproterone acetate. British Journal of Dermatology 1973a; 89: 487–490
- Burton J. L., Cartlidge M., Cartlidge N. E. F., Schuster S. Sebum secretion in parkinsonism. British Journal of Dermatology 1973b; 88: 263–266
- Davis J. M. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 1976; 33: 858–861
- Ebling F. J. Hormonal control and methods of measuring sebaceous gland activity. The Journal of Investigative Dermatology 1974; 62: 161–171
- Kane J. M., Woerner M., Lieberman J. Tardive dyskinesia: prevalence, incidence and risk factors. Journal of Clinical Psychopharmacology 1988; 8: 52S–56S, (suppl)
- Kidger T., Barnes T. R. E., Trauer T., Taylor P. J. Sub-syndromes of tardive dyskinesia. Psychological Medicine 1980; 10: 513–520
- Gurejee O. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors. Psychological Medicine 1989; 19: 121–128
- Mooradian A. D., Morley J. E., Korenman S. G. Biological actions of androgens. Endocrine Reviews 1987; 8: 1–28
- Schooler N. R., Kane J. M. Research diagnoses for tardive dyskinesia. Archives of General psychiatry 1982; 39: 486–487
- Simpson G., Lee J., Zoubok B., Cole J. O., Gardos G. A rating scale for tardive dyskinesia. Psychophatrmacology 1979; 64: 171–179